BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8269717)

  • 1. Establishment of red fluorescent protein-tagged HeLa tumor metastasis models: determination of DsRed2 insertion effects and comparison of metastatic patterns after subcutaneous, intraperitoneal, or intravenous injection.
    Lu JY; Chen HC; Chu RY; Lin TC; Hsu PI; Huang MS; Tseng CJ; Hsiao M
    Clin Exp Metastasis; 2003; 20(2):121-33. PubMed ID: 12705633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of fluorescent lung carcinoma metastasis model and its real-time microscopic detection in SCID mice.
    Huang MS; Wang TJ; Liang CL; Huang HM; Yang IC; Yi-Jan H; Hsiao M
    Clin Exp Metastasis; 2002; 19(4):359-68. PubMed ID: 12090477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases.
    Yang M; Baranov E; Jiang P; Sun FX; Li XM; Li L; Hasegawa S; Bouvet M; Al-Tuwaijri M; Chishima T; Shimada H; Moossa AR; Penman S; Hoffman RM
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1206-11. PubMed ID: 10655509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiopharmaceuticals for cardiac imaging.
    Miller DD; Elmaleh DR; McKusick KA; Boucher CA; Callahan RJ; Strauss HW
    Radiol Clin North Am; 1985 Dec; 23(4):765-81. PubMed ID: 3906755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New radiopharmaceuticals and new applications in medicine.
    Teates CD; Parekh JS
    Curr Probl Diagn Radiol; 1993; 22(6):229-66. PubMed ID: 8269717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET in oncology: will it replace the other modalities?
    Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
    Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status and prospects of new radionuclides and radiopharmaceuticals for cardiovascular nuclear medicine.
    Schelbert HR
    Semin Nucl Med; 1987 Apr; 17(2):145-81. PubMed ID: 3296198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer.
    Neal CE; Meis LC
    Semin Nucl Med; 1994 Oct; 24(4):272-85. PubMed ID: 7817200
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.